StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.89+0.18 (+10.53%)

Close on Nov 18, 2026Market cap $3.00MP/E –Yield –

Silo Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Silo Pharma's revenue for the twelve months ending Jun 30, 2026 was $54.08K, down 25.0% year over year. For fiscal 2025 it was $72.10K, up 0.0% from the year before. The highest annual figure on record is $72.10K in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.10K0.0%
FY2024Dec 31, 2024$72.10K0.0%
FY2023Dec 31, 2023$72.10K0.0%
FY2022Dec 31, 2022$72.10K+76.2%
FY2020Dec 31, 2020$40.92K+0.9%
FY2019Dec 31, 2019$40.57K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$18.03K0.0%
Q4 FY2025Dec 31, 2025$18.03K0.0%
Q3 FY2025Sep 30, 2025$18.03K0.0%
Q2 FY2025Jun 30, 2025$18.03K-0.0%
Q1 FY2025Mar 31, 2025$18.03K-50.0%
Q4 FY2024Dec 31, 2024$18.03K0.0%
Q3 FY2024Sep 30, 2024$18.03K0.0%
Q4 FY2023Dec 31, 2023$18.03K+0.0%
Q1 FY2023Jun 30, 2023$36.05K-47.1%
Q4 FY2022Dec 31, 2022$18.03K-62.0%
Q3 FY2022Sep 30, 2022$18.03K-18.5%
Q2 FY2022Jun 30, 2022$18.03K+10.7%
Q2 FY2021Jun 30, 2021$68.09K+2972.4%
Q1 FY2021Mar 31, 2021$47.43K+16033.7%
Q4 FY2020Dec 31, 2020$22.13K-45.1%
Q3 FY2020Sep 30, 2020$16.29K+5976.5%
Q2 FY2020Jun 30, 2020$2.22K–
Q1 FY2020Mar 31, 2020$294–
Q4 FY2019Dec 31, 2019$40.30K–
Q3 FY2019Sep 30, 2019$268–

More Silo Pharma figures

See a number that looks wrong?